#Japan #Setagaya #Metallo-Balance #Renatech #K Medical Clinic

Launch of the Metallo-Balance Test

In an exciting development for health screenings, K Medical Clinic in Setagaya, Tokyo, has announced the commencement of reservations for the innovative Metallo-Balance Test starting in October. Developed by Renatech, this screening test requires just a small 6mL blood sample to evaluate risks for cancer and mild cognitive impairment (MCI). As a part of the continuous effort to provide reliable health assessment services, this test opens new avenues for health management in the local community.

What is the Metallo-Balance Test?

The Metallo-Balance Test analyzes the concentration balance of 17 trace elements in the blood, allowing for an objective assessment of cancer and MCI risk. This risk screening test not only helps individuals gain insights into their health status but also serves as a preventive measure for potential diseases.

Test Features

• - Minimal Blood Sample: The test requires only a single blood draw of 6mL, performed under strict safety protocols within medical facilities. The procedure takes around 15 minutes, minimizing discomfort for participants.
• - Comprehensive Cancer Risk Evaluation: The test provides risk evaluations for multiple types of cancer, categorizing them based on gender. Men are screened for six types, including lung, stomach, and prostate cancers, while women are examined for nine types, including breast, cervical, and ovarian cancers.
• - Extensive MCI Risk Assessment: In addition to Alzheimer’s type, the test also includes other forms of cognitive impairment, ensuring a thorough evaluation.

Proven Research and Recognition

The Metallo-Balance Test boasts solid research foundations and validation both domestically and internationally. Supported by grants from the Ministry of Economy, Trade and Industry, it has been developed in collaboration with the Kanagawa Prefectural Cancer Center and the Chiba Cancer Center. The test has secured patents in nine countries worldwide and has seen over 100,000 participants since its launch in April 2019.

How to Take the Test

Application Process

To participate, individuals are required to apply approximately three weeks ahead of their desired test date due to necessary document handling. Applications can be submitted via the website or by phone.

• - Upon registration, test materials will be sent to your home a week prior to the scheduled date.
• - On the test day, participants will undergo a smooth and efficient blood collection, with post-test billing for their convenience.

Important Pre-Test Guidelines

Participants must avoid eating or drinking alcohol from 9 PM the evening before the test and ensure adequate hydration. Over-the-counter medications and supplements should be refrained from the day before. However, prescribed medications can be taken as usual.

Test Pricing

The Metallo-Balance Test is classified as private pay (not covered by health insurance). Tests are priced as follows:

• - Cancer Risk Test: ¥19,800 (tax included)
• - MCI Risk Test: ¥19,800 (tax included)
• - Combined Cancer & MCI Risk Test: ¥24,200 (tax included)

Who Can Take the Test?

• - Cancer Risk: Individuals aged between 20 and 80 years in Japan.
• - MCI Risk: Individuals aged between 50 and 80 years in Japan.

Though those outside these age ranges or of foreign nationality can take the test, results may be considered as reference values only. Participants in certain conditions, such as pregnant individuals or those currently undergoing cancer treatment, are restricted from taking the test.

K Medical Clinic Overview

• - Testing Days: Primarily Monday through Friday (excluding holidays).
• - Address: 4-12-5 Minami-Karasuyama, Setagaya, Tokyo, TS Karasuyama Building 3F.
• - Access: Just a one-minute walk from Chitose-Karasuyama Station on the Keio Line.
• - Available Tests: Cancer Risk Test, MCI Risk Test.

For more information regarding test availability and to make reservations, visit the Metallo-Balance Test website.

Renatech continues to focus on advancing health screening technologies, committed to social contributions through innovative health solutions. Stay tuned for more updates on this pivotal development in health management.